
Sandeep Singh
About Sandeep Singh
Data last updated:
Sandeep Singh is a Managing Director at Alkem Laboratories Limited (since 2013), Director at Enzene Biosciences Limited (since 2011) and Director at Alkem Foundation (since 2019), and holds 12 more current directorships. The companies operate in Pharma, Life Sciences and Education. The 9 current companies with reported revenue have a combined latest revenue of ₹15,738 Cr; the largest is Alkem Laboratories Limited at ₹15,296 Cr (FY 2026). Earlier, Sandeep Singh was a Director at Propstack Services Private Limited (2014–2015) and Designated Partner at Alkem Real Estate Llp (from 2012) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 09 Aug 2013 | 1973 | ₹15,296 Cr (FY 2026) | Active | |
| Director | 20 Oct 2011 | 2006 | ₹385 Cr (FY 2025) | Active | |
| Director | 28 May 2019 | 2010 | ₹35.31 Cr (FY 2025) | Active | |
| Director | 11 Jun 2020 | 2020 | ₹10.14 Cr (FY 2025) | Active | |
| Director | 24 Apr 2025 | 2021 | ₹5.87 Cr (FY 2024) | Active | |
| Director | 26 Aug 2019 | 2019 | ₹3.96 Cr (FY 2025) | Active | |
| Nominee Director | 21 Aug 2025 | 2015 | ₹2.13 Cr (FY 2025) | Active | |
| Individual Subscriber | 16 Sep 2024 | 2024 | ₹6.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Nov 2014 | 2013 | ₹5.75 Cr (FY 2024) | Active | |
| Designated Partner | 31 Oct 2012 | 2012 | Strike Off | ||
| Director | 12 Aug 2004 | 2004 | Strike Off | ||
| Director | 16 Aug 2019 | 2012 | Strike Off | ||
| Director | 16 Aug 2019 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sandeep Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandeep Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandeep Singh
Sandeep Singh currently holds 15 directorships: Alkem Laboratories Limited (Managing Director, since 09 Aug 2013, revenue ₹15,296 Cr (FY 2026)); Enzene Biosciences Limited (Director, since 20 Oct 2011, revenue ₹385 Cr (FY 2025)); Alkem Foundation (Director, since 28 May 2019, revenue ₹35.31 Cr (FY 2025)); Connect 2 Clinic Private Limited (Director, since 11 Jun 2020, revenue ₹10.14 Cr (FY 2025)); Alkem Medtech Ortho Private Limited (Director, since 24 Apr 2025, revenue ₹5.87 Cr (FY 2024)); and 10 more.
Sandeep Singh was first appointed on 12 Aug 2004 as Director at White Coal Investments Private Limited. The most recent appointment on record is 01 Dec 2025 at Samnan Bioscience Private Limited.
The 9 current companies of Sandeep Singh that report revenue have a combined latest revenue of ₹15,738 Cr: Alkem Laboratories Limited ₹15,296 Cr (FY 2026); Enzene Biosciences Limited ₹385 Cr (FY 2025); Alkem Foundation ₹35.31 Cr (FY 2025); Connect 2 Clinic Private Limited ₹10.14 Cr (FY 2025); Alkem Medtech Ortho Private Limited ₹5.87 Cr (FY 2024); and 4 more.
Sandeep Singh held 5 earlier board appointments: Propstack Services Private Limited (Director, 16 Nov 2014 to 09 Jun 2015); Alkem Real Estate Llp (Designated Partner, from 31 Oct 2012); White Coal Investments Private Limited (Director, from 12 Aug 2004); Ashadeep Private Limited (Director, from 16 Aug 2019); Nanhamati And Samprada Singh Private Limited (Director, from 16 Aug 2019).
The current boards of Sandeep Singh's companies include Basudeo Narayan Singh (Alkem Laboratories Limited), Diwakar Gupta (Alkem Laboratories Limited), Laxmana Ranjal Shenoy (Alkem Laboratories Limited), Madhurima Singh (Alkem Laboratories Limited), Manish Narang (Alkem Laboratories Limited), Mritunjay Kumar Singh (Alkem Laboratories Limited), among others.